Brain and nerve = Shinkei kenkyu no shinpo · 2025
[A Novel Subtype of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL): Pro-hemorrhagic CADASIL].
СтатьяОбзорАннотация на английскомНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ishiyama Hiroyuki, Saito Satoshi, Ihara Masafumi
Аннотация
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common type of hereditary small-vessel disease causing early onset stroke and dementia. The classic CADASIL phenotype predominantly features ischemic lesions, including lacunar infarcts and white matter lesions notably involving bilateral temporal poles. However, hemorrhagic phenotypes such as intracerebral hemorrhage (ICH) and cerebral microbleeds (CMB) are increasingly being recognized, particularly among East Asian populations, compared to those of European descent, suggesting underlying genetic differences. The East Asian-specific NOTCH3 p.R75P variant shows a higher prevalence of hemorrhagic phenotypes, such as ICH and multiple CMB, typically without temporopolar lesions. Structural and pathological analyses revealed that, unlike conventional CADASIL variants, which produce extensive deposition of NOTCH3 extracellular domains in the vascular walls, the p.R75P variant exhibits reduced aggregation, providing a plausible biological explanation for its unique clinical phenotype. This review highlights the distinctive pro-hemorrhagic phenotype associated with the NOTCH3 p.R75P variant, synthesizing current insights into its genetic, pathological, clinical, and radiological features. Enhanced understanding of this variant will broaden the phenotypic spectrum of CADASIL, emphasizing the need for tailored clinical strategies for susceptible populations.